New Zealand: John Duncan appointed to PEB board

Cancer diagnostics company Pacific Edge has appointed John Duncan to the board as an independent director. “John brings extensive international experience with Macquarie Group and Hill Samuel at senior levels in investment banking, financial and capital markets advisory and mergers and acquisitions,” said chairman Chris Gallaher. “In particular; John’s experience in Asian markets, including Japan…

You must be a HMI Subscriber to view this content.

Subscribe Now »